Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients switching tumor necrosis factor α inhibitor therapy: Results from the Danish nationwide DANBIO registry.

Bente Glintborg; Mikkel Østergaard; N.S. Krogh; U. Tarp; N. Manilo; A.G. Loft; Annette Hansen; Annette Schlemmer; V. Fana; Hanne Merete Lindegaard; H. Nordin; C. Rasmussen; L. Ejstrup; Dorte Vendelbo Jensen; P. Mosborg-Petersen; Merete Lund Hetland

Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients switching tumor necrosis factor α inhibitor therapy: Results from the Danish nationwide DANBIO registry.

Bente Glintborg, Mikkel Østergaard, N.S. Krogh, U. Tarp, N. Manilo, A.G. Loft, Annette Hansen, Annette Schlemmer, V. Fana, Hanne Merete Lindegaard, H. Nordin, C. Rasmussen, L. Ejstrup, Dorte Vendelbo Jensen, P. Mosborg-Petersen, Merete Lund Hetland

Original language	English
Book series	Scandinavian Journal of Rheumatology. Supplement
Volume	41
Issue number	126 suppl.
Pages (from-to)	40-1
Number of pages	2
ISSN	1502-7740
Publication status	Published - 2012

Cite this

Glintborg, B., Østergaard, M., Krogh, N. S., Tarp, U., Manilo, N., Loft, A. G., Hansen, A., Schlemmer, A., Fana, V., Lindegaard, H. M., Nordin, H., Rasmussen, C., Ejstrup, L., Jensen, D. V., Mosborg-Petersen, P., & Hetland, M. L. (2012). Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients switching tumor necrosis factor α inhibitor therapy: Results from the Danish nationwide DANBIO registry. Scandinavian Journal of Rheumatology. Supplement, 41(126 suppl.), 40-1.

Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients switching tumor necrosis factor α inhibitor therapy: Results from the Danish nationwide DANBIO registry. / Glintborg, Bente; Østergaard, Mikkel; Krogh, N.S. et al.

In: Scandinavian Journal of Rheumatology. Supplement, Vol. 41, No. 126 suppl., 2012, p. 40-1.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Glintborg, B, Østergaard, M, Krogh, NS, Tarp, U, Manilo, N, Loft, AG, Hansen, A, Schlemmer, A, Fana, V, Lindegaard, HM, Nordin, H, Rasmussen, C, Ejstrup, L, Jensen, DV, Mosborg-Petersen, P & Hetland, ML 2012, 'Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients switching tumor necrosis factor α inhibitor therapy: Results from the Danish nationwide DANBIO registry.', Scandinavian Journal of Rheumatology. Supplement, vol. 41, no. 126 suppl., pp. 40-1.

@article{74953e2029fd426fbdc243794c00e737,

title = "Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients switching tumor necrosis factor α inhibitor therapy: Results from the Danish nationwide DANBIO registry.",

author = "Bente Glintborg and Mikkel {\O}stergaard and N.S. Krogh and U. Tarp and N. Manilo and A.G. Loft and Annette Hansen and Annette Schlemmer and V. Fana and Lindegaard, {Hanne Merete} and H. Nordin and C. Rasmussen and L. Ejstrup and Jensen, {Dorte Vendelbo} and P. Mosborg-Petersen and Hetland, {Merete Lund}",

year = "2012",

language = "English",

volume = "41",

pages = "40--1",

journal = "Acta rheumatologica Scandinavica",

issn = "0301-3847",

publisher = "Taylor & Francis",

number = "126 suppl.",

}

TY - ABST

T1 - Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients switching tumor necrosis factor α inhibitor therapy: Results from the Danish nationwide DANBIO registry.

AU - Glintborg, Bente

AU - Østergaard, Mikkel

AU - Krogh, N.S.

AU - Tarp, U.

AU - Manilo, N.

AU - Loft, A.G.

AU - Hansen, Annette

AU - Schlemmer, Annette

AU - Fana, V.

AU - Lindegaard, Hanne Merete

AU - Nordin, H.

AU - Rasmussen, C.

AU - Ejstrup, L.

AU - Jensen, Dorte Vendelbo

AU - Mosborg-Petersen, P.

AU - Hetland, Merete Lund

PY - 2012

Y1 - 2012

M3 - Conference abstract in journal

SN - 0301-3847

VL - 41

SP - 40

EP - 41

JO - Acta rheumatologica Scandinavica

JF - Acta rheumatologica Scandinavica

IS - 126 suppl.

ER -